Objective: The short- and medium-term consequences of the economic crisis since 2008 has become a cause of concern for population health. The study's objective was to analyse health inequalities according to the socioeconomic profile of the Catalan population aged 50 year and older.
Methods: Cross-sectional study using data from the Catalan Health Survey (ESCA) for the periods 2006 (N=6667), 2010-12 (N=4458) y 2013-15 (N=5469). The dependent variables were self-perceived health, mental health, medication intake and sedentary lifestyle and the independent variables: labour force activity status, educational level, health care coverage, household social class and household monthly income. On each dependent variable multivariate logistic analysis was conducted using Stata 14, adjusting for the remaining socioeconomic factors and other demographic variables, and estimating the average marginal effects for each socioeconomic category in the three observation moments.
Results: Between 2006 and 2013-15 the difference in the probability of having less than good self-perceived health among the population with or without double health coverage reduced from 0.06 to 0.04; between the most and least educated from 0.12 to 0.08; but did not reduce between workers and non-workers. The gap according to employment status, educational levels and income in the risk of poor mental health increased between 2006 and 2010-12 from 0.08 to 0.10, from 0.10 to 0.12 and from 0.10 to 0.13, although subsequently, inequality decreased. Difference in medication intake increased by employment status (from 0.07 to 0.10) and educational level (from -0.01 to 0.03) and in sedentary lifestyles between workers and non-workers (from 0, 05 to 0.06). Socioeconomic conditions had more impact on 50-64 year olds, especially women, while social inequality declined among men.
Conclusions: Despite the crisis health generally improved, while socioeconomic health inequalities remained or reduced, barring few exceptions.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11587267 | PMC |
Health Policy Plan
January 2025
Department of Anthropology, Durham University, South Road, Durham, DH1 3LE, UK.
Substandard and falsified (SF) medical products are a serious health and economic concern that disproportionately impact low- and middle-income countries and marginalized groups. Public education campaigns are demand-side interventions that may reduce risk of SF exposure, but the effectiveness of such campaigns, and their likelihood of benefitting everybody, is unclear. Nationwide pilot risk communication campaigns, involving multiple media, were deployed in Ghana, Nigeria, Sierra Leone, Uganda in 2020-2021.
View Article and Find Full Text PDFBlood Adv
January 2025
University of North Carolina at Chapel Hill, CHAPEL HILL, North Carolina, United States.
A wealth of research focused on African American populations has connected rs2814778-CC ("Duffy-null") to decreased neutrophil (neutropenia) and leukocyte counts (leukopenia). While it has been proposed that this variant is benign, prior studies have shown that the misinterpretation of Duffy-null associated neutropenia and leukopenia can lead to unnecessary bone marrow biopsies, inequities in cytotoxic and chemotherapeutic treatment courses, under-enrollment in clinical trials, and other disparities. To investigate the phenotypic correlates of Duffy-null status, we conducted a phenome-wide association study (PheWAS) across more than 1,400 clinical conditions in All of Us, the Vanderbilt University Medical Center's Biobank, and the Million Veteran Program.
View Article and Find Full Text PDFEpilepsia
January 2025
Department of Neurology, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
Objective: To assess whether social determinants of health (SDOHs) are associated with the first antiseizure medication (ASM) prescribed for newly diagnosed epilepsy.
Methods: The Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) standards were followed, and the protocol registered (CRD42023448998). Embase, Medline, and Web of Science were searched up to July 31, 2023.
Diabet Med
January 2025
Usher Institute, Medical School, University of Edinburgh, Edinburgh, UK.
Background: Trials conducted in highly selected populations have shown that type 2 diabetes (T2D) remission is possible, but the feasibility and acceptability of supporting remission in routine clinical practice remain uncertain.
Aim: We explored primary care professionals' perceptions and understandings of T2D remission and their views about supporting remission within routine clinical care.
Methods: Semi-structured interviews were conducted with 14 GPs and nine nurses working in Scottish general practices.
BMC Public Health
January 2025
Grupo de Investigación en Servicios Sanitarios de Aragón (GRISSA), Fundación Instituto de Investigación Sanitaria de Aragón (IIS Aragón), Zaragoza, Spain.
Background: European guidelines recommend the prescription of certain drugs after acute myocardial infarction (AMI). The existence of gender differences in pharmacological treatment after an AMI has been described. This study aims to describe and analyse, using real-world data (RWD), whether there are gender differences in the prescribing patterns and initiation of treatment in secondary prevention after a first AMI, and which are the factors that explain these differences.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!